BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best beginner stocks to buy, according to analysts. On September 6, ...

Are pharma companies pulling their money out of the U.K. because of Trump? And how is biotech M&A pacing this year?

Innovative Pharmaceutical Biotech ( ($HK:0399) ) just unveiled an announcement. Innovative Pharmaceutical Biotech Limited has announced a further ...

Upfront fees and near-term development milestone payments totaling up to $7.5 millionPotential sales milestones of $180 ...

About eighteen years ago, when I was still a computer scientist, very few credible scientists, and entrepreneurs were interested in aging research or longevity. There were very few conferences and ...

In addition, under its strategic agreement with Novartis, Sironax granted the pharmaceutical company an exclusive option to ...

DUBLIN--(BUSINESS WIRE)--The "European Pharmaceutical Directory 2023" directory has been added to ResearchAndMarkets.com's offering. The market potential of the European biotechnology and ...

The global market for cleanroom consumables is projected to reach $19.4 billion by 2033, exhibiting a robust compound annual growth rate (CAGR) of 5.4% over the forecast period. This expansion is ...

LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical ...

Biotechnology products account for a major portion of Iran’s pharmaceutical exports, with a share of 60 percent.

Synmosa plans to acquire 15% to 30% of Genovate at NT$24 (US$0.80) per share, valuing the maximum stake at around NT$827 ...

Research Summary:Extant research suggests that firms rationally evaluate external and/or internal contingencies when deciding how to reconfigure their alliance portfolios. We advance a behavioral ...